6-mercaptopurine

No definition available.

Endpoint definition

FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC L01BB02
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector RX_L01BB02

Extra metadata

First used in FinnGen datafreeze DF4

Summary Statistics

Key figures

All Female Male
Number of individuals 398 222 176
Unadjusted prevalence (%) 0.15 0.15 0.16
Mean age at first event (years) 44.67 43.67 45.93

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.14 10.15 [3.92, 26.26] 1.8e-6 14
15 years 0.07 9.52 [3.62, 25.06] 5.0e-6 13
5 years - - - -
1 year - - - -

Correlations

Index endpoint: RX_L01BB02 – 6-mercaptopurine
GWS hits:

Survival analyses between endpoints

Plot

before 6-mercaptopurine
after 6-mercaptopurine

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after 6-mercaptopurine